Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The 16 week duration of this trial meant that rapid dose escalation of survodutide over 6 weeks was required to allow for 10 weeks of treatment and drug exposure with the maintenance dose in each DG
Limitations of Use: Tirzepatide should not be used in combination with other tirzepatide-containing products or any other GLP-1 receptor agonist The safety and efficacy of coadministration with other products for weight loss have not been established Tirzepatide has not been studied in patients with a history of pancreatitis Tirzepatide should not be used in patients with type 1 diabetes mellitus Who should not use tirzepatide
Continue With Professional Guidance Its hard to lose weight by yourself
All participants gave written informed consent before enrollment into the study
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals predispositions in four key peptide pathways: GLP-1 receptor function, GIPR sensitivity, FTO-related metabolic regulation, and melanocortin-4 receptor signaling
Adequate time for washout and weight stabilization before conception
